Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 17428 | 27.02 |
09:34 ET | 9608 | 27.15 |
09:36 ET | 5078 | 27.11 |
09:38 ET | 2192 | 27.09 |
09:39 ET | 1100 | 27.08 |
09:41 ET | 400 | 27.08 |
09:43 ET | 5212 | 26.99 |
09:45 ET | 5866 | 26.98 |
09:48 ET | 1900 | 26.98 |
09:50 ET | 1276 | 26.93 |
09:52 ET | 1700 | 26.885 |
09:54 ET | 3400 | 26.905 |
09:56 ET | 1200 | 26.925 |
09:57 ET | 4161 | 26.965 |
09:59 ET | 775 | 26.97 |
10:01 ET | 3662 | 26.91 |
10:03 ET | 18910 | 26.91 |
10:06 ET | 5545 | 26.9239 |
10:08 ET | 4447 | 26.875 |
10:10 ET | 8643 | 26.865 |
10:12 ET | 4800 | 26.83 |
10:14 ET | 3501 | 26.81 |
10:15 ET | 4200 | 26.802 |
10:17 ET | 2853 | 26.795 |
10:19 ET | 5028 | 26.7724 |
10:21 ET | 19526 | 26.785 |
10:24 ET | 8652 | 26.755 |
10:26 ET | 6670 | 26.74 |
10:28 ET | 4529 | 26.77 |
10:30 ET | 21411 | 26.74 |
10:32 ET | 1700 | 26.73 |
10:33 ET | 1300 | 26.755 |
10:35 ET | 3442 | 26.785 |
10:37 ET | 3229 | 26.8119 |
10:39 ET | 2385 | 26.8 |
10:42 ET | 8347 | 26.82 |
10:44 ET | 3575 | 26.78 |
10:46 ET | 28570 | 26.78 |
10:48 ET | 10020 | 26.775 |
10:50 ET | 16783 | 26.74 |
10:51 ET | 10635 | 26.735 |
10:53 ET | 8901 | 26.74 |
10:55 ET | 6233 | 26.735 |
10:57 ET | 22476 | 26.73 |
11:00 ET | 11118 | 26.745 |
11:02 ET | 5545 | 26.74 |
11:04 ET | 2421 | 26.745 |
11:06 ET | 5513 | 26.745 |
11:08 ET | 400 | 26.745 |
11:09 ET | 6426 | 26.735 |
11:11 ET | 5905 | 26.755 |
11:13 ET | 11247 | 26.735 |
11:15 ET | 4778 | 26.725 |
11:18 ET | 25020 | 26.705 |
11:20 ET | 25746 | 26.735 |
11:22 ET | 5355 | 26.74 |
11:24 ET | 2600 | 26.74 |
11:26 ET | 4655 | 26.745 |
11:27 ET | 2750 | 26.755 |
11:29 ET | 2050 | 26.755 |
11:31 ET | 10257 | 26.785 |
11:33 ET | 13405 | 26.845 |
11:36 ET | 7206 | 26.865 |
11:38 ET | 5050 | 26.895 |
11:40 ET | 9925 | 26.885 |
11:42 ET | 4276 | 26.865 |
11:44 ET | 3507 | 26.87 |
11:45 ET | 2112 | 26.88 |
11:47 ET | 20200 | 26.79 |
11:49 ET | 3154 | 26.815 |
11:51 ET | 1816 | 26.815 |
11:54 ET | 2192 | 26.825 |
11:56 ET | 2495 | 26.815 |
11:58 ET | 3608 | 26.84 |
12:00 ET | 2697 | 26.83 |
12:02 ET | 2671 | 26.82 |
12:03 ET | 1700 | 26.8 |
12:05 ET | 3688 | 26.8 |
12:07 ET | 700 | 26.795 |
12:09 ET | 1000 | 26.805 |
12:12 ET | 5700 | 26.795 |
12:14 ET | 300 | 26.795 |
12:16 ET | 6169 | 26.775 |
12:18 ET | 3861 | 26.8 |
12:20 ET | 1802 | 26.785 |
12:21 ET | 3471 | 26.8 |
12:23 ET | 750 | 26.7909 |
12:25 ET | 2748 | 26.83 |
12:27 ET | 5050 | 26.865 |
12:30 ET | 400 | 26.875 |
12:32 ET | 6537 | 26.87 |
12:34 ET | 1436 | 26.89 |
12:36 ET | 11454 | 26.845 |
12:38 ET | 22343 | 26.8599 |
12:39 ET | 177 | 26.8549 |
12:41 ET | 1400 | 26.865 |
12:43 ET | 4798 | 26.87 |
12:45 ET | 3801 | 26.86 |
12:50 ET | 1572 | 26.87 |
12:52 ET | 100 | 26.865 |
12:54 ET | 3777 | 26.865 |
12:56 ET | 5201 | 26.83 |
12:57 ET | 3100 | 26.865 |
12:59 ET | 5644 | 26.85 |
01:01 ET | 1052 | 26.845 |
01:03 ET | 2418 | 26.85 |
01:06 ET | 3508 | 26.855 |
01:08 ET | 3560 | 26.855 |
01:10 ET | 757 | 26.865 |
01:12 ET | 500 | 26.86 |
01:14 ET | 1859 | 26.865 |
01:15 ET | 3931 | 26.86 |
01:17 ET | 4036 | 26.86 |
01:19 ET | 1738 | 26.875 |
01:21 ET | 1898 | 26.875 |
01:24 ET | 9250 | 26.86 |
01:26 ET | 3999 | 26.87 |
01:28 ET | 907 | 26.88 |
01:30 ET | 2671 | 26.87 |
01:32 ET | 3357 | 26.875 |
01:33 ET | 537 | 26.875 |
01:35 ET | 700 | 26.88 |
01:37 ET | 1630 | 26.88 |
01:39 ET | 400 | 26.87 |
01:42 ET | 2415 | 26.88 |
01:44 ET | 8227 | 26.895 |
01:46 ET | 589 | 26.9 |
01:48 ET | 2094 | 26.935 |
01:50 ET | 13494 | 26.945 |
01:51 ET | 5907 | 26.96 |
01:53 ET | 5461 | 26.96 |
01:55 ET | 5265 | 26.935 |
01:57 ET | 1877 | 26.92 |
02:00 ET | 2616 | 26.915 |
02:02 ET | 1700 | 26.925 |
02:04 ET | 8651 | 26.925 |
02:06 ET | 1200 | 26.95 |
02:08 ET | 6175 | 26.965 |
02:09 ET | 4321 | 26.97 |
02:11 ET | 4485 | 26.99 |
02:15 ET | 4878 | 26.995 |
02:18 ET | 10638 | 26.98 |
02:20 ET | 861 | 26.985 |
02:22 ET | 3363 | 26.98 |
02:24 ET | 3154 | 26.995 |
02:26 ET | 3095 | 27 |
02:27 ET | 1000 | 26.995 |
02:29 ET | 9301 | 27 |
02:31 ET | 391 | 26.995 |
02:33 ET | 7069 | 26.995 |
02:36 ET | 8961 | 26.995 |
02:38 ET | 1002 | 26.995 |
02:40 ET | 20182 | 26.97 |
02:42 ET | 2683 | 26.985 |
02:44 ET | 2300 | 27 |
02:45 ET | 3669 | 27 |
02:47 ET | 4199 | 27 |
02:49 ET | 2901 | 26.995 |
02:51 ET | 4590 | 26.995 |
02:54 ET | 19859 | 27.04 |
02:56 ET | 10008 | 27.015 |
02:58 ET | 5795 | 27 |
03:00 ET | 3371 | 26.995 |
03:02 ET | 5759 | 26.97 |
03:03 ET | 6131 | 26.96 |
03:05 ET | 4745 | 26.985 |
03:07 ET | 2949 | 26.965 |
03:09 ET | 2556 | 26.945 |
03:12 ET | 4681 | 26.98 |
03:14 ET | 4277 | 26.975 |
03:16 ET | 2225 | 26.975 |
03:18 ET | 1621 | 26.985 |
03:20 ET | 6572 | 26.975 |
03:21 ET | 2883 | 26.975 |
03:23 ET | 2957 | 26.965 |
03:25 ET | 6676 | 26.95 |
03:27 ET | 4632 | 26.935 |
03:30 ET | 3216 | 26.925 |
03:32 ET | 9268 | 26.9301 |
03:34 ET | 5486 | 26.96 |
03:36 ET | 5690 | 26.955 |
03:38 ET | 4512 | 26.955 |
03:39 ET | 7949 | 26.965 |
03:41 ET | 3614 | 26.955 |
03:43 ET | 1971 | 26.955 |
03:45 ET | 19760 | 26.995 |
03:48 ET | 12132 | 26.995 |
03:50 ET | 8877 | 26.985 |
03:52 ET | 16681 | 26.945 |
03:54 ET | 12408 | 26.935 |
03:56 ET | 22059 | 26.915 |
03:57 ET | 36783 | 26.96 |
03:59 ET | 223466 | 26.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.1B | 15.1x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.2x | --- |
Catalent Inc | 10.0B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 7.1B | 23.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.4x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.1B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.12% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.